Toprak, Z. Et Al. 2017. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.. International urology and nephrology , vol.49 , 1041-1047.

Toprak, Z., Cebecı, E., Helvacı, S., Toprak, I., Kutlu, Y., Sakin, A., ... Tukek, T.(2017). Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.. International urology and nephrology , vol.49, 1041-1047.

Toprak, Z Et Al. "Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.," International urology and nephrology , vol.49, 1041-1047, 2017

Toprak, Z Et Al. "Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.." International urology and nephrology , vol.49, pp.1041-1047, 2017

Toprak, Z. Et Al. (2017) . "Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.." International urology and nephrology , vol.49, pp.1041-1047.

@article{article, author={Z Toprak Et Al. }, title={Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.}, journal={International urology and nephrology}, year=2017, pages={1041-1047} }